Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 315,055	$ 146,726	$ 707,970	$ 242,060
Cost of revenue	56,040	54,543	172,559	99,067
Operating expenses:
Research and development	235,696	368,553	579,401	855,770
General and administrative	1,503,553	3,696,517	3,936,700	5,712,762
Total operating expenses	1,739,249	4,065,070	4,516,101	6,568,532
Loss from operations	(1,480,234)	(3,972,887)	(3,980,690)	(6,425,539)
Other income (expense), net:
Change in fair value of derivative warrant liabilities	72,591	1,454,440	99,353	1,454,440
Reverse recapitalization issuance costs in excess of gross proceeds		(6,566,821)		(6,566,821)
Interest expense	(3,977)		(11,595)	(77)
Other expense, net				(426,666)
Total other income (expense), net	68,614	(5,112,381)	87,758	(5,539,124)
Net loss and comprehensive loss	(1,411,620)	(9,085,268)	(3,892,932)	(11,964,663)
Less: accretion of convertible preferred stock to redemption value	(85,872)	(201,168)	(172,688)	(201,168)
Net loss attributable to common stockholders	$ (1,497,492)	$ (9,286,436)	$ (4,065,620)	$ (12,165,831)
Net loss per share attributable to common stockholders - basic	$ (0.08)	$ (1.14)	$ (0.21)	$ (2.75)
Net loss per share attributable to common stockholders - diluted	$ (0.08)	$ (1.14)	$ (0.21)	$ (2.75)
Weighted-average number of common shares used in computing net loss per share attributable to common stockholders - basic	19,154,681	8,142,383	19,094,394	4,430,401
Weighted-average number of common shares used in computing net loss per share attributable to common stockholders - diluted	19,154,681	8,142,383	19,094,394	4,430,401